• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Schrodinger, Inc. - Common Stock (NQ:SDGR)

17.59 -0.87 (-4.71%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
August 14, 2026
From Schrödinger
Via Business Wire
News headline image
Schrödinger (SDGR) Q2 2026 Earnings Call Transcript ↗
August 12, 2026
AI co-scientist Bunsen drives productivity gains amid software model shift. 
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
AI Found an Influenza Target That Survives Viral Mutation
August 10, 2026
Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT) 
From Equity Insider
Via GlobeNewswire
Schrodinger (NASDAQ:SDGR) Q2 Results Beat Expectations; Guidance Raised ↗
August 05, 2026
Via Chartmill
Schrödinger Inc (NASDAQ:SDGR) Q1 2026 Earnings: Revenue Beat Fails to Offset Loss Miss, Stock Slides ↗
May 05, 2026
Via Chartmill
Schrödinger Inc (NASDAQ:SDGR) Posts Q4 Earnings Beat Amid Strategic Software Model Shift ↗
February 25, 2026
Via Chartmill
Topics Earnings
News headline image
Schrodinger Q2 Earnings Call Highlights ↗
August 06, 2026
Schrodinger (NASDAQ:SDGR) said second-quarter annual contract value growth accelerated as demand broadened across large pharmaceutical customers, biotechnology companies and materials-science... 
Via MarketBeat
Topics Artificial Intelligence Earnings
News headline image
Schrödinger Reports Second Quarter 2026 Financial Results
August 05, 2026
From Schrödinger
Via Business Wire
News headline image
Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery
August 05, 2026
From Schrödinger
Via Business Wire
News headline image
Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery
July 27, 2026
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Announce Second Quarter 2026 Financial Results on August 5
July 22, 2026
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 20, 2026
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 18, 2026
From Schrödinger
Via Business Wire
News headline image
Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026? ↗
June 02, 2026
Two AI-driven disruptors, one biotech-focused, one software-first, post double-digit growth but diverge sharply on risk, cash flow, and valuation. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 22, 2026
From Schrödinger
Via Business Wire
News headline image
My Top 3 Biotech Stocks for May 2026 ↗
May 20, 2026
As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, select biotech companies are beginning to stand out from the crowd. 
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
Schrödinger (SDGR) Q1 2026 Earnings Transcript ↗
May 05, 2026
Schrödinger (SDGR) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Schrödinger Reports First Quarter 2026 Financial Results
May 05, 2026
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Participate in Upcoming Investor Conferences
May 04, 2026
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Announce First Quarter 2026 Financial Results on May 5
April 21, 2026
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 17, 2026
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 18, 2026
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results
February 25, 2026
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Participate in Upcoming Investor Conferences
February 24, 2026
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 18, 2026
From Schrödinger
Via Business Wire
News headline image
The Biotechnology Renaissance: AI and Capital Collide in a Multi-Trillion Dollar Pivot
February 17, 2026
As of February 17, 2026, the biotechnology sector is undergoing its most significant structural transformation in decades, a period now widely termed the "Biotechnology Renaissance." Following a... 
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25
February 11, 2026
From Schrödinger
Via Business Wire
News headline image
AI’s ‘Penicillin Moment’: How Generative Models Are Slashing Decades of Antibiotic Research into Months
February 06, 2026
In a breakthrough that many are calling the "Penicillin Moment" of the 21st century, researchers at the Massachusetts Institute of Technology, led by bioengineering pioneer James Collins, have... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
January 22, 2026
The U.S. biotech sector has officially entered a new golden age. As of January 22, 2026, the industry is witnessing a "renaissance" that has effectively erased the memories of the grueling three-year... 
Via MarketMinute
Topics Artificial Intelligence ETFs Initial Public Offering
News headline image
From Silicon to Syringes: Nvidia’s AI Dominance Solidified Through Landmark Eli Lilly Alliance
January 12, 2026
In a move that signals the definitive convergence of high-performance computing and biotechnology, NVIDIA Corporation (NASDAQ: NVDA) and Eli Lilly and Company (NYSE: LLY) announced a massive $1 billion... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap